Biocryst Pharmaceuticals (BCRX) Asset Utilization Ratio (2011 - 2026)

Biocryst Pharmaceuticals has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.98 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 5.54% year-over-year to 0.98; the trailing twelve-month figure through Mar 2026 stood at 0.98 (down 5.54% YoY), and the FY2025 full-year result was 1.74, up 94.64% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.98, roughly flat from 0.98 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 1.33 in Q3 2025, with the low at 0.34 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.76 across 5 years, with a median of 0.72 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 225.55% — and 2026, when it declined 5.54%.
• Biocryst Pharmaceuticals' Asset Utilization Ratio stood at 0.49 in 2022, then jumped by 30.46% to 0.64 in 2023, then soared by 44.06% to 0.92 in 2024, then gained by 6.34% to 0.98 in 2025, then rose by 0.37% to 0.98 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.98 (Q1 2026), 0.98 (Q4 2025), and 1.33 (Q3 2025), per Business Quant data.